Life Sciences Tools & Services (69) | Intellectual Property (69)

Browse by Subcategory

License Agreements (68)
Trademark Agreements (1)

Browse by Company

10x Genomics, Inc. (4)
AbCellera Biologics Inc. (4)
Akoya Biosciences, Inc. (3)
Berkeley Lights, Inc. (2)
ChromaDex Corp. (6)
CODEXIS INC (5)
Cytek BioSciences, Inc. (1)
ECO SCIENCE SOLUTIONS, INC. (1)
EVIO, INC. (1)
FLUIDIGM CORP (6)
IsoPlexis Corp (5)
Miromatrix Medical Inc. (22)
NanoString Technologies Inc (2)
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (1)
Quanterix Corp (2)
RAPID MICRO BIOSYSTEMS, INC. (1)
Seer, Inc. (1)
SeqLL, Inc. (1)
Singular Genomics Systems, Inc. (1)

Recent Contracts

Tenth Amendment to the License Agreement, dated March 31, 2022, by and between Miromatrix Medical Inc. and Mayo Foundation for Medical Education and Research (Miromatrix Medical Inc., Filed With SEC on May 16, 2022)
First Amendment to the Amended and Restated Exclusive License Agreement, effective as of December 29, 2020, between Dartmouth College and ChromaDex, Inc (ChromaDex Corp., Filed With SEC on May 12, 2022)
Second Amendment to the Amended and Restated Exclusive License Agreement, effective as of January 1, 2022, between Dartmouth College and ChromaDex, Inc (ChromaDex Corp., Filed With SEC on May 12, 2022)
Side letter agreement to the Amended and Restated Exclusive License Agreement, effective as of March 13, 2019, between Dartmouth College and ChromaDex, Inc (ChromaDex Corp., Filed With SEC on May 12, 2022)
Restated and Amended Exclusive License Agreement, effective as of March 13, 2017, between Dartmouth College and ChromaDex, Inc (ChromaDex Corp., Filed With SEC on May 12, 2022)
Exclusive License Agreement, dated February 4, 2004, between the Registrant and The Institute for Systems Biology (NanoString Technologies Inc, Filed With SEC on May 10, 2022)
Amendment No. 1 to Exclusive License Agreement, dated February 5, 2007, between the Registrant and The Institute for Systems Biology (NanoString Technologies Inc, Filed With SEC on May 10, 2022)
Nineth Amendment to the License Agreement, dated October 21, 2021, by and between Miromatrix Medical Inc. and Mayo Foundation for Medical Education and Research (Miromatrix Medical Inc., Filed With SEC on March 30, 2022)
Eighth amendment to the Mayo License Agreement dated October 21, 2021 between the Company and Mayo Foundation for Medical Education and Research (Miromatrix Medical Inc., Filed With SEC on November 15, 2021)
Exclusive License Agreement, dated September 8, 2011, by and between ChromaDex, Inc. and The Regents of the University of California v (ChromaDex Corp., Filed With SEC on November 3, 2021)